Keywords: Lundbeck, Investment, Ossianix, CNS products, Onfi, Epilepsy, USA launch

Lundbeck invests in Ossianix; debuts Onfi in USA

Article | 03 January 2012

Print This

Privately-held US company Ossianix announced a strategic investment by Danish CNS drug specialist Lundbeck A/S (LUND: DC) in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in